Source: International Congress 2016 – Lung involvement in systemic disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Jay Ryu (Rochester, United States of America). IgG4 disease and the lung. International Congress 2016 – Lung involvement in systemic disorders

Member's Comments

No comment yet.

Related content which might interest you: Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD) Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Altered Fc galactosylation in IgG4 is a potential serum marker for chronic lung disease Source: ERJ Open Res, 4 (3) 00033-2018; 10.1183/23120541.00033-2018 Year: 2018 Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody Source: Eur Respir Rev 2015; 24: 370-372 Year: 2015 Autoantibodies in interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Siphonage lung disease Source: Virtual Congress 2020 – Respiratory critical care Year: 2020 KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Pulmonary manifestations of immunoglobulin G4-related sclerosing disease Source: Eur Respir J 2011; 39: 180-186 Year: 2012 Pulmonary manifestations of immunoglobulin G4-related sclerosing disease Source: Eur Respir J 2012; 39: 180-186 Year: 2012 High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003 Mild parenchymal lung disease is still lung disease Source: Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020 Year: 2020 Mild parenchymal lung disease is still lung disease Source: Eur Respir J, 56 (5) 2003542; 10.1183/13993003.03542-2020 Year: 2020 Subsequent COPD and lung cancer in patients with autoimmune disease Source: Eur Respir J 2011; 37: 463 Year: 2011 Usefulness of serum bird specific antibody levels in patients with interstitial pneumonia Source: International Congress 2016 – Orphan diseases II Year: 2016 IgG4 as a potential biomarker of acute exacerbations in ILD Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 A clinicopathological review of interstitial pneumonia with marked IgG4 positive plasma cells infiltration Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Serum biomarkers as prognostic factors of autoimmune pulmonary alveolar proteinosis after whole lung lavage Source: International Congress 2016 – Orphan diseases I Year: 2016 Anti periplakin antibodies in connective tissue-associated lung fibrosis Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Nitrofurantoin-induced interstitial lung disease Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Serum CYFRA reflects disease severity of autoimmune pulmonary alveolar proteinosis Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010